Most recently, SRPK2 expression was shown to be higher in colorectal cancer tumors compared to nontumor tissues, and was positively associated with tumor differentiation, primary tumor (T) stage, regional lymph nodes (N) stage, and UICC stage (59). Here, SRPK2 is linked to colorectal cancer.